Original article by Clay Lucas
The Sydney Morning Herald – Page: Online : 11-Nov-21
Pathological group Australian Clinical Labs has been a beneficiary of both the federal government’s COVID-19 testing program and the JobKeeper wage subsidy. The company’s revenue increased by 29 per cent in 2020-21, while its after-tax profit rose from $11.7m to $88.7m. Australian Clinical Labs received JobKeeper payments totalling $34.3m over the last two financial years, but it repaid just $21.9m. Australian Clinical Labs’ annual report for 2020 notes that revenue fell sharply in the months immediately following the onset of the pandemic in March of that year, making the firm eligible for JobKeeper. The company also receives a government subsidy for every COVID-19 test it performs.
CORPORATES
AUSTRALIAN CLINICAL LABS LIMITED – ASX ACL